Citation: Bh. Schmidt et R. Heinig, THE PHARMACOLOGICAL BASIS FOR METRIFONATES FAVORABLE TOLERABILITY IN THE TREATMENT OF ALZHEIMERS-DISEASE, Dementia and geriatric cognitive disorders, 9, 1998, pp. 15-19
Citation: Jg. Moller et al., CAPILLARY-ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE - A ROUTINEMETHOD TO DETERMINE MOXIFLOXACIN IN HUMAN-BODY FLUIDS IN VERY SMALL SAMPLE VOLUMES, Journal of chromatography B. Biomedical sciences and applications, 716(1-2), 1998, pp. 325-334
Citation: R. Heinig et al., PHARMACOKINETICS OF THE CONTROLLED-RELEASE NISOLDIPINE COAT-CORE TABLET FORMULATION, International journal of clinical pharmacology and therapeutics, 35(8), 1997, pp. 341-351
Authors:
SCHAEFER HG
HEINIG R
AHR G
ADELMANN H
TETZLOFF W
KUHLMANN J
Citation: Hg. Schaefer et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING AS A TOOL TO EVALUATE THE CLINICAL RELEVANCE OF A DRUG-FOOD INTERACTION FOR A NISOLDIPINE CONTROLLED-RELEASE DOSAGE FORM, European Journal of Clinical Pharmacology, 51(6), 1997, pp. 473-480
Citation: G. Wensing et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF BAY-X-7195 AEROSOL, A NEW AND SELECTIVE RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, IN NORMAL VOLUNTEERS, British journal of clinical pharmacology, 42(2), 1996, pp. 171-178
Authors:
MICHELUCCI R
CIPOLLA G
PASSARELLI D
GATTI G
OCHAN M
HEINIG R
TASSINARI CA
PERUCCA E
Citation: R. Michelucci et al., REDUCED PLASMA NISOLDIPINE CONCENTRATIONS IN PHENYTOIN-TREATED PATIENTS WITH EPILEPSY, Epilepsia, 37(11), 1996, pp. 1107-1110
Citation: R. Heinig, DETERMINATION OF BAYX7195, A NOVEL LEUKOTRIENE D-4 ANTAGONIST, IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH POSTCOLUMN PHOTO DERIVATIZATION AND FLUORESCENCE DETECTION, Journal of chromatography B. Biomedical applications, 667(1), 1995, pp. 137-147
Authors:
HEINIG R
SCHAEFER HG
WENSING G
KUHLMANN J
Citation: R. Heinig et al., PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE ORALLY-ADMINISTERED RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES BAY-X-7195 IN SINGLE-DOSE ESCALATION STUDIES, International journal of clinical pharmacology and therapeutics, 33(10), 1995, pp. 573-579
Citation: R. Heinig et al., DETERMINATION OF THE ENANTIOMERS OF NISOLDIPINE IN HUMAN PLASMA USINGHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON A CHIRAL STATIONARY-PHASE AND GAS-CHROMATOGRAPHY WITH MASS-SELECTIVE DETECTION, Journal of chromatography B. Biomedical applications, 655(2), 1994, pp. 286-292
Authors:
WENSING G
HEINIG R
PRIESNITZ M
KUHLMANN J
Citation: G. Wensing et al., EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS, European Journal of Clinical Pharmacology, 47(3), 1994, pp. 227-230
Authors:
WENSING G
HEINIG R
PRIESNITZ M
KUHLMANN J
Citation: G. Wensing et al., EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS, European Journal of Clinical Pharmacology, 47(3), 1994, pp. 227-230
Citation: G. Wensing et al., EFFECT OF THE LEUKOTRIENE D-4 (LTD(4))-RECEPTOR ANTAGONIST BAY X 7195ON LTD(4)-INDUCED BRONCHOCONSTRICTION IN NORMAL SUBJECTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 203-203
Citation: Sr. Rabel et al., IMPROVEMENTS IN DETECTION SENSITIVITY FOR THE DETERMINATION OF IVERMECTIN IN PLASMA USING CHROMATOGRAPHIC TECHNIQUES AND LASER-INDUCED FLUORESCENCE DETECTION WITH AUTOMATED DERIVATIZATION, Journal of chromatography. Biomedical applications, 617(1), 1993, pp. 79-86